Last reviewed · How we verify

Duloxetine or escitalopram

New York State Psychiatric Institute · FDA-approved active Small molecule Quality 5/100

Duloxetine or escitalopram is a Small molecule drug developed by New York State Psychiatric Institute. It is currently FDA-approved. Also known as: Cymbalta or Lexapro.

At a glance

Generic nameDuloxetine or escitalopram
Also known asCymbalta or Lexapro
SponsorNew York State Psychiatric Institute
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Duloxetine or escitalopram

What is Duloxetine or escitalopram?

Duloxetine or escitalopram is a Small molecule drug developed by New York State Psychiatric Institute.

Who makes Duloxetine or escitalopram?

Duloxetine or escitalopram is developed and marketed by New York State Psychiatric Institute (see full New York State Psychiatric Institute pipeline at /company/new-york-state-psychiatric-institute).

Is Duloxetine or escitalopram also known as anything else?

Duloxetine or escitalopram is also known as Cymbalta or Lexapro.

What development phase is Duloxetine or escitalopram in?

Duloxetine or escitalopram is FDA-approved (marketed).

Related